Results 151 to 160 of about 15,465 (199)

A novel stop-loss variant in ISG15 causes C-terminal dysfunction and impairs USP18-mediated negative feedback. [PDF]

Front Immunol
Zhang W, Chen X, Li Y, Yao X, Huang J, Gao Y, Xing W, Lu D, Deng M, Shu Z, Mao H.   +10 more
europepmc   +1 more source

Comparative Effectiveness and Safety of Baricitinib and Ritlecitinib in Severe Alopecia Areata: A Real-World Monocentric Retrospective Study. [PDF]

Dermatol Ther (Heidelb)
D'Oria F, Di Giulio S, Ibba L, Falcidia C, Foggi G, Vignoli CA, Facheris P, Gargiulo L, Cascio Ingurgio R, Costanzo A, Narcisi A, Valenti M.   +11 more
europepmc   +1 more source

Low-dose baricitinib plus danazol in primary immune thrombocytopenia: a randomized, controlled phase 2 trial. [PDF]

Nat Commun
Zhao P, An ZY, Fu HX, Wang Y, Feng GS, Liu HX, Liu DH, Liu Y, Zhou HB, Liu H, Wang Z, Dong YJ, Jing HM, Li ZL, Li LH, Dou LP, Huang QS, Wu J, Yang LP, Jin Y, Li ZX, Wang CC, Chen Q, Zhu XL, He Y, Zhang YY, Jiang Q, Jiang H, Lu J, Chang YJ, Zhao XY, Huang XJ, Zhang XH.   +32 more
europepmc   +1 more source

JAK inhibitors and adverse cardiovascular events: Class effect or molecule-specific risk? [PDF]

Front Pharmacol
Radić M, Bečić T, Prižmić PŠ, Pavlović MR, Vučković M, Radić J, Borovac JA, Fajkić A, Belančić A.   +8 more
europepmc   +1 more source

High-Dose Baricitinib for Severe Alopecia Areata with Suboptimal Response to Conventional Therapy: A Real-World Assessment. [PDF]

Clin Cosmet Investig Dermatol
Liu Q, Sun M, Cao Y, Zhao H.
europepmc   +1 more source

Enhancing Lipid Nanoparticle-Mediated Circular RNA and mRNA Expression in the Placenta through Inhibition of IFNAR-JAK-STAT Signaling. [PDF]

Nano Lett
Safford HC, Geisler HC, Thatte AS, Liao KC, Poirier A, Padilla M, Yamagata HM, Agrawal A, Murray AM, Hamilton AG, Swingle KL, Fitzgerald E, Chalom O, Wan Y, Mitchell MJ.   +14 more
europepmc   +1 more source

Treatment of concomitant alopecia areata and systemic lupus erythematosus with ivarmacitinib: a case report and literature review. [PDF]

Front Med (Lausanne)
Li W, Zhang Z, Huang R, Mei Y, Shen Z, Chu Y.   +5 more
europepmc   +1 more source

Nicotinamide-mediated clinical improvement in CEBPE-related immunodeficiency. [PDF]

Pediatr Allergy Immunol
Dwivedi P, Gulkari A, Gupta A, Deshpande K, Dhabale T, Kapse A, Bohra A, Choudhari S, Watchmaker J, Pathak A.   +9 more
europepmc   +1 more source

JAK Inhibitor Safety in Atopic Dermatitis and Alopecia Areata: A 4.5-Year Real-World Retrospective Cohort Study. [PDF]

Dermatol Ther (Heidelb)
Facheris P, Gargiulo L, Ibba L, Valenti M, D'Oria F, Foggi G, Falcidia C, Di Giulio S, Vignoli CA, Costanzo A, Narcisi A.   +10 more
europepmc   +1 more source

Baricitinib for Itch-Dominant Atopic Dermatitis: A 52-week Baricitinib Real-World Experience in Korea. [PDF]

Ann Dermatol
Hong N, Gwag HE, Park SY, Heo SJ, Jung HJ, Park MY, Choi YS, Ahn J.   +7 more
europepmc   +1 more source